{"title":"F18 FDG PET/CT对半瘤性和非半瘤性睾丸肿瘤的再分期和随访","authors":"E. El-kholy, H. Fathy, N. Elliethy","doi":"10.21608/egyjnm.2019.46184","DOIUrl":null,"url":null,"abstract":"Aim: to evaluate the role of FDG PET/CT in restaging and follow up of Seminomatous and non Seminomatous testicular tumors. Materials and methods: 54 patients (mean age: 34.2 ±11.8) with pathologically proven testicular cancer in whom FDG PET/CT were retrospectively assessed. Total 89 PET/CT studies were conducted in comparison to diagnostic CT. Pathological and clinical/radiological follow-up for 6-15 months duration served as standards of reference. Results: Seminomas type was more prevalent (64.8%). 30% of patients did not develop metastases during their course of disease. While 38 patients develop metastatic lesions (31 had abdominal nodal deposits and 5 patients had distant sites and 2 patients presented by both).The lung was the most common site for distant metastases. All 33 patients with recurrent lesions had regional abdominal nodal deposits, while distant metastasis was more detected in 9 patients with Non Seminomatous pathology. FDG PET/CT had higher sensitivity, specificity, and accuracy of 94%, 86.5%, and 92.5% versus 76%, 85% 83%; for diagnostic CT in per patients analysis. A total of 90 lesions were reported, (62 nodal & 28 distant) metastatic lesions were analyzed. PET/CT showed good accuracy for the detection of residual/recurrent Seminomatus lesions, with an overall sensitivity and specificity of 94.7 % and 93.3 %, respectively compared to 89.2% and 56.2% for diagnostic CT, their size mean + SD (3.9+-3.1) and SUV max (7+-6.3).Non Seminomatus distant metastases showed comparable results for both PET/CT and diagnostic CT with false negative results in small sized (mainly lung lesions). 25 patients had single PET/CT; its results with diagnostic CT were comparable in 20 patients (84%), while 29 patients with repeated 64 PET/CT studies had comparable analysis to diagnostic CT in 22 patients (~76%). In the other 7 patients (~24%), a higher value of PET/CTin assessment of therapy response was noted. PET/CT shows CMR in 5 patients that remain stationary in CT based on size difference analysis. Conclusion: The current study showed that 18FDG-PET/CT is useful in re-staging & assessment of response on patients with Germ cell testicular tumor as compared to CT regarding Seminomatous abdominal nodal lesions and non Seminomatous distant disease.","PeriodicalId":202063,"journal":{"name":"The Egyptian Journal Nuclear Medicine","volume":"53 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Restaging and Follow up of Seminomatous and Non Seminomatous Testicular Tumors Using F18 FDG PET/CT.\",\"authors\":\"E. El-kholy, H. Fathy, N. Elliethy\",\"doi\":\"10.21608/egyjnm.2019.46184\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: to evaluate the role of FDG PET/CT in restaging and follow up of Seminomatous and non Seminomatous testicular tumors. Materials and methods: 54 patients (mean age: 34.2 ±11.8) with pathologically proven testicular cancer in whom FDG PET/CT were retrospectively assessed. Total 89 PET/CT studies were conducted in comparison to diagnostic CT. Pathological and clinical/radiological follow-up for 6-15 months duration served as standards of reference. Results: Seminomas type was more prevalent (64.8%). 30% of patients did not develop metastases during their course of disease. While 38 patients develop metastatic lesions (31 had abdominal nodal deposits and 5 patients had distant sites and 2 patients presented by both).The lung was the most common site for distant metastases. All 33 patients with recurrent lesions had regional abdominal nodal deposits, while distant metastasis was more detected in 9 patients with Non Seminomatous pathology. FDG PET/CT had higher sensitivity, specificity, and accuracy of 94%, 86.5%, and 92.5% versus 76%, 85% 83%; for diagnostic CT in per patients analysis. A total of 90 lesions were reported, (62 nodal & 28 distant) metastatic lesions were analyzed. PET/CT showed good accuracy for the detection of residual/recurrent Seminomatus lesions, with an overall sensitivity and specificity of 94.7 % and 93.3 %, respectively compared to 89.2% and 56.2% for diagnostic CT, their size mean + SD (3.9+-3.1) and SUV max (7+-6.3).Non Seminomatus distant metastases showed comparable results for both PET/CT and diagnostic CT with false negative results in small sized (mainly lung lesions). 25 patients had single PET/CT; its results with diagnostic CT were comparable in 20 patients (84%), while 29 patients with repeated 64 PET/CT studies had comparable analysis to diagnostic CT in 22 patients (~76%). In the other 7 patients (~24%), a higher value of PET/CTin assessment of therapy response was noted. PET/CT shows CMR in 5 patients that remain stationary in CT based on size difference analysis. Conclusion: The current study showed that 18FDG-PET/CT is useful in re-staging & assessment of response on patients with Germ cell testicular tumor as compared to CT regarding Seminomatous abdominal nodal lesions and non Seminomatous distant disease.\",\"PeriodicalId\":202063,\"journal\":{\"name\":\"The Egyptian Journal Nuclear Medicine\",\"volume\":\"53 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Egyptian Journal Nuclear Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/egyjnm.2019.46184\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Egyptian Journal Nuclear Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/egyjnm.2019.46184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨FDG PET/CT在半胱氨酸瘤和非半胱氨酸瘤睾丸肿瘤再分期及随访中的作用。材料与方法:回顾性分析经病理证实的54例睾丸癌患者(平均年龄:34.2±11.8岁)的FDG PET/CT表现。共进行了89项PET/CT研究,与诊断性CT进行了比较。病理及临床/影像学随访6-15个月为参照标准。结果:精原细胞瘤类型较多(64.8%)。30%的患者在病程中未发生转移。38例患者发生转移性病变(31例为腹部淋巴结沉积,5例为远处病灶,2例为两种情况)。肺是最常见的远处转移部位。33例复发病变均为腹部区域性结节沉积,9例非半细胞瘤病理多见远处转移。FDG PET/CT的敏感性、特异性和准确性分别为94%、86.5%和92.5%,高于76%、85%和83%;诊断性CT在每个病人的分析。报告了90例病灶,分析了62例淋巴结转移灶和28例远处转移灶。PET/CT对半间瘤残余/复发病变的检测准确率较高,总体敏感性为94.7%,特异度为93.3%,而诊断性CT的敏感性为89.2%,特异度为56.2%,其大小平均值+ SD (3.9+-3.1), SUV max(7+-6.3)。非半瘤状远处转移在PET/CT和诊断性CT上的结果相当,在小的(主要是肺病变)中显示假阴性结果。单次PET/CT 25例;20例(84%)患者的结果与诊断性CT具有可比性,而29例重复64次PET/CT研究的患者的结果与22例(~76%)的诊断性CT具有可比性。在其他7例患者(~24%)中,PET/CTin评估治疗反应的值较高。基于尺寸差异分析,PET/CT显示5例患者的CMR在CT上保持平稳。结论:目前的研究表明,与CT相比,18FDG-PET/CT对睾丸生殖细胞肿瘤患者腹部半胱癌结节病变和非半胱癌远处病变的再分期和疗效评估是有用的。
Restaging and Follow up of Seminomatous and Non Seminomatous Testicular Tumors Using F18 FDG PET/CT.
Aim: to evaluate the role of FDG PET/CT in restaging and follow up of Seminomatous and non Seminomatous testicular tumors. Materials and methods: 54 patients (mean age: 34.2 ±11.8) with pathologically proven testicular cancer in whom FDG PET/CT were retrospectively assessed. Total 89 PET/CT studies were conducted in comparison to diagnostic CT. Pathological and clinical/radiological follow-up for 6-15 months duration served as standards of reference. Results: Seminomas type was more prevalent (64.8%). 30% of patients did not develop metastases during their course of disease. While 38 patients develop metastatic lesions (31 had abdominal nodal deposits and 5 patients had distant sites and 2 patients presented by both).The lung was the most common site for distant metastases. All 33 patients with recurrent lesions had regional abdominal nodal deposits, while distant metastasis was more detected in 9 patients with Non Seminomatous pathology. FDG PET/CT had higher sensitivity, specificity, and accuracy of 94%, 86.5%, and 92.5% versus 76%, 85% 83%; for diagnostic CT in per patients analysis. A total of 90 lesions were reported, (62 nodal & 28 distant) metastatic lesions were analyzed. PET/CT showed good accuracy for the detection of residual/recurrent Seminomatus lesions, with an overall sensitivity and specificity of 94.7 % and 93.3 %, respectively compared to 89.2% and 56.2% for diagnostic CT, their size mean + SD (3.9+-3.1) and SUV max (7+-6.3).Non Seminomatus distant metastases showed comparable results for both PET/CT and diagnostic CT with false negative results in small sized (mainly lung lesions). 25 patients had single PET/CT; its results with diagnostic CT were comparable in 20 patients (84%), while 29 patients with repeated 64 PET/CT studies had comparable analysis to diagnostic CT in 22 patients (~76%). In the other 7 patients (~24%), a higher value of PET/CTin assessment of therapy response was noted. PET/CT shows CMR in 5 patients that remain stationary in CT based on size difference analysis. Conclusion: The current study showed that 18FDG-PET/CT is useful in re-staging & assessment of response on patients with Germ cell testicular tumor as compared to CT regarding Seminomatous abdominal nodal lesions and non Seminomatous distant disease.